The Biosecure Act is a significant legislative proposal aimed at reshaping the pharmaceutical supply chain landscape, particularly concerning the sourcing of pharmaceutical products and services by US federal government bodies. The Act focuses on enhancing national security by reducing dependency on foreign pharmaceutical entities, especially those from China
LifeScience WorldWide’s Post
More Relevant Posts
-
220 & 155 Sterilization / Medical devices, committees member ICONTEC Colombia and Healthcare Technical Consulting of MSS (Medical Service Science)
The most cost effective low temperature sterilization process available for healthcare devices always find the way to get bigger in time
STERIS is excited to share that Singapore is now home to the latest EO processing site in our global network! 🇸🇬 Read the full announcement here: https://lnkd.in/eNVaYxPk STERIS is proud to support medical device and pharmaceutical manufacturers worldwide with a technology-neutral service offering that includes both radiation and gas processing options. The addition of the Singapore facility complements our existing electron beam, gamma, X-ray, and microbiological testing services in Malaysia, Thailand, and China. #Singapore #PatientSafety #Sustainability #MedicalDevices #Pharmaceuticals
-
-
How can Bangladesh's pharmaceutical sector boost efficiency and guarantee safe medicine access? This ADB Brief explores regulatory reforms to enhance the country's manufacturing of vaccines and other pharmaceutical products. It draws on global best practices and offers policy opportunities to strengthen Bangladesh's public health and emergency preparedness. https://ow.ly/AKkW50Sh0yg
-
-
Exploring Pharmaceutical Regulations and Registration in South Korea Curious about the intricate world of pharmaceutical regulations in South Korea? Dive deep into the nuances with our latest blog post on Artixio's website! From understanding Good Manufacturing Practices (GMP) to navigating registration processes, we've got you covered. At Artixio, we specialize in providing comprehensive insights into regulatory frameworks worldwide, empowering pharmaceutical companies to thrive in complex markets. With our expertise, you can confidently navigate the regulatory landscape and ensure compliance every step of the way. Ready to unlock the potential of the South Korean pharmaceutical market? Click the link below to read our blog post and gain valuable insights! 💡 https://lnkd.in/gsQufnci #Artixio #PharmaceuticalRegulations #SouthKorea #GMP #Compliance #RegulatoryInsights #PharmaceuticalIndustry #MFDS
Pharmaceutical Regulation Registration South Korea MFDS
artixio.com
-
📌 FREE WEBINAR | International Expansion in the #UK Pharmaceutical Market: News and Opportunities 📅 February 27, 2024 🕒3:00- 3:40 p.m. CET 💻 Virtual ↪️ Prepared to embark on an exploration of the current #Regulatory landscape in the #UK, discovering the latest #RegulatoryUpdates and the significant changes in the #drugregistration process in the #BritishMarket, with a focus on the #WindsorFramework? Then join ASPHALION expert Mireia Roig Aubert on this #webinar! 🔗 Registrations are open. You can register here: https://bit.ly/49dwcXA 📧 For further information you can contact us at: info@asphalion.com https://bit.ly/42lCcLJ #PharmaceuticalMarket #Pharma #FreeWebinar #Procedures #InternationalStrategies #InternationalExpansion #UnitedKingdom #MHRA #News #Opportunities #Updates #Regulatory #MeetTheExpert #RA #RegulatoryAffairs #WeAreAsphalion #WeCare #KnowledgeFromExperience
WEBINAR | International Expansion in the UK Pharmaceutical Market: News and Opportunities
https://www.asphalion.com
-
📌 FREE WEBINAR | International Expansion in the UK Pharmaceutical Market: News and Opportunities ↪️Ready to explore the latest news on the #UK #pharmaceuticalmarket and what is to come? ↪️In our next webinar, you will dive into the latest #developments and #opportunities offered by the UK pharmaceutical market and discover #keystrategies for #internationalexpansion. ↪️ Join ASPHALION expert Mireia Roig Aubert, our #RegulatoryAffairs Associate Manager, and discover all the latest #updates while she goes over: 🌐 International Reliance Strategies: #ProjectOrbis #AccessConsortium #InternationalRecognitionProcedure 📑 Regulatory landscape in the UK: #Windsorframework 🔗 Registrations are open. You can register here: https://bit.ly/49dwcXA 📧 For further information you can contact us at: info@asphalion.com https://bit.ly/42lCcLJ #WEBINAR #FreeWebinar #Procedures #InternationalStrategies #InternationalExpansion #News #Opportunities #Updates #Regulatory #MeetTheExpert #RA #RegulatoryAffairs #WeAreAsphalion #WeCare #KnowledgeFromExperience
WEBINAR | International Expansion in the UK Pharmaceutical Market: News and Opportunities
https://www.asphalion.com
-
Independent Senior Consultant in Health Policy, HTA and HEOR and Personal Chair Professor
No doubt, the HTAR-EU is a game changer in pharmaceutical market access! The national policy questions and assessment needs translated into joint PICO scoping will inform the JCA. This will be "taking into account” the developer’s information to be sent to the HTA Secretariat (EC) at the same time as application to the EMA for marketing approval. This will really put the HTA agencies in the driver’s seat! https://lnkd.in/eGuZDv38 #HTA #regulation #eu #pharmaceuticals #HTAR #marketaccess
-
-
Discover the intricate web of challenges facing East Africa's pharmaceutical supply chain and explore innovative solutions poised to transform the landscape. From infrastructure limitations to regulatory complexities and counterfeit drug concerns, this article delves into the pain points obstructing efficient distribution. Through insights into future solutions such as technology adoption, regulatory harmonization, and public-private partnerships, gain a glimpse into a roadmap for a more resilient and effective pharmaceutical supply chain in the region.
Navigating Pain Points in East Africa’s Pharmaceutical Supply Chain: A Roadmap to Future Solutions
link.medium.com
-
🔴 New RTF Mechanism for Pharmaceutical Registration in Hong Kong 🔴 Starting on 1 July 2024, the Pharmacy and Poisons Board of Hong Kong will enforce the Refuse-to-File (RTF) mechanism for pharmaceutical products/substances registration applications. This new protocol will require applicants to respond to the authority within the timeframe given to avoid being refused filing during the screening stage. Stay updated with ARQon for important updates! https://lnkd.in/dE7-aDZU #RegulatoryUpdate #AttopolisB2B #ArqonGroup #ComplianceUpdate #HealthcareInnovation #HongKong #Registration #RTFMechanism #PharmaceuticalProducts #ScreeningStage #PharmacyandPoisonsBoard
-
-
Closing registrations soon for the Impurities MasterClass - EU Edition: https://lnkd.in/gCMYrRCf Venture into the multifaceted world of pharmaceutical impurities with our dedicated MasterClass, sculpted specifically for the EU audience. This virtual session aims to illuminate the complexities, identification processes, and regulatory framework surrounding pharmaceutical impurities. 🗓️ Dates: 29th - 30th January, 2024 🌍 Location: Virtual 🎓 Speaker: Markus Veit This MasterClass beckons all professionals eager to elevate their understanding of pharmaceutical impurities, a cornerstone for drug safety and efficacy. Seats are being claimed quickly, so please make sure you act now! Join us and navigate the intricate pharmaceutical impurities with precision and confidence! #masterclass #glceurope #globalleadingconferences #pharmaceuticalimpurities #drugsafety #regulatorycompliance
-
-
Pharmaceutical Advertising 2024 | Chambers and Partners Global Practice Guide Francisca Paulouro and Ana Isabel Lopes contribute to the guide "Pharmaceutical Advertising 2024" published by Chambers and Partners in the Global Practice Guide segment. VdA's lawyers sign the chapter "Portugal: Trends & Developments", in which they analyse the legal regime applicable to the advertising of pharmaceutical products in Portugal. Through this analysis, Francisca Paulouro and Ana Isabel Lopes explain the reasons why Portuguese legislation in this matter is stricter than the common European Union standard. This publication is available here (https://lnkd.in/dKMD7grB) #VdA #ChambersandPartners #Pharmaceutical #Advertising
-